Interleukin-4 and cardiac fibrosis in patients with heart failure;Interleucina-4 y fibrosis miocárdica en pacientes con insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 60, Issue 7, 2007, Pages 777-780

  Roselló Lletí, Esther ^a   Rivera Otero, Miguel ^a   Bertomeu, Vicente ^b   Cortés, Raquel ^a   Jordán, Alejandro ^c   González Molina, Andrés ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Fibrosis; Heart failure; Interleukin 4

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; INTERLEUKIN 4; INTERLEUKIN 6; MARKER; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; URINE LEVEL; CONGESTIVE HEART FAILURE; FIBROSIS; HEART MUSCLE; PATHOLOGY; URINE;

AGED; FEMALE; FIBROSIS; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-4; MALE; MYOCARDIUM;

EID: 34548027473     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13108284     Document Type: Article

References (11)

1. Thompson LO, Skrabal CA, Loebe M, Lafuente JA, Roberts RR, Akgul A. Plasma neurohormone level correlated with left ventricular functional and morphological improvement in LVAD patients. J Surg Res. 2005;123:25-32.
2. Anker SD, Von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464-70.
3. Fairweather D, Frisancho-Kiss S, Yusung S, Barrett M, Davis S, Gatewood S, et al. Interferon γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-β1, inteleukin-1β, and interleukin-4 in the heart. AJP. 2004;165:1883-94.
4. Harber M, Sundstedt A, Wraith D. The role of cytokines in immunological tolerance: potential for therapy. Exp Rev Mol Med. 2000;2000:1-20.
5. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol. 1995;75:913-8.
6. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart descompensation. Clin Cardiol. 1999;22:811-3.
7. Kapadia S, Lee J, Torre AG, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-a gene and protein espression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995; 96:1042-52.
8. McGaha TL, Le M, Kodera T, Stoica C, Zhu J, Paul WE, et al. Molecular mechanisms of interleukin-4-induced upregulation of type I collagen gene expression in murine fibroblasts. Arthritis Rheum. 2003;48:2275-84.
9. Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, Zangrilli JG, et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy. 2004;34:437-44.
10. Rivera M, Roselló-Lletí E, García de Burgos F, Bertomeu V, Payá R, Cortés R, et al. Valores de 8-hidroxi-2′-desoxiguanosina y de peroxidación lipídica en pacientes con insuficiencia cardiaca. Rev Esp Cardiol. 2006;59:1140-5.
11. López B, González A, Querejeta R, Larman M, Díez J. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol. 2006;48:89-96.